Parkinson’s Disease (PD) is a chronic and progressive neurological disorder, that affects a person's movement, balance, and coordination. It is related to a deficiency of the neurotransmitter dopamine, which is responsible for transmitting signals from the brain to the rest of the body. Risk factors for PD include aging, genetic predisposition, family history, and environmental exposures. Symptoms of Parkinson’s usually appear gradually, and can worsen over time. Common symptoms include shaking, rigidity, slow movement, difficulty with walking, and impaired balance. In some cases, speech may be affected, and depression can also be a symptom. In its early stages, treatment is typically symptomatic, meaning it focuses on alleviating the symptoms of the disease. Medication is one possible treatment, and these drugs typically act to increase dopamine levels in the brain. In addition to medications, physical therapists may be used to help maintain mobility and coordination. Sometimes, treatments such as deep brain stimulation or even surgical operations may be recommended. While there is no cure for Parkinson’s, early diagnosis is key to a successful treatment plan and improved quality of life. It is important for people with Parkinson’s to take part in regular physical activity, and other forms of exercise, to help maintain mobility and improve balance. In addition, people with PD should pay close attention to their diets and nutritional needs to ensure they get the nutrients they need. Support from family and friends is also important, and many people with Parkinson’s turn to support groups to get specialized advice and guidance.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States